Tenofovir Disoproxil Fumarate in the Clinical Practice: An Overview

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 15, 2 Issues, 2017

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Tenofovir Disoproxil Fumarate in the Clinical Practice: An Overview

Anti-Infective Agents, 7(4): 285-295.

Author(s): Maria Foggia, Salvatore Nappa, Giovanni Bonadies, Mariarosaria Cotugno, Giovanni Di Filippo, Francesco Borrelli, Raffaele Orlando and Guglielmo Borgia.

Affiliation: Professor of Infectious Diseases, Department of Medicina Pubblica e Sicurezza Sociale, Section of Infectious Diseases, University of Naples - Federico II, Naples, Italy.


Tenofovir disoproxil fumarate (tenofovir DF) is the generic name of the chemical compound 9- [R- (2[[bis]]isopropoxycarbonyl) oxy]methoxy]phosphonyl]methoxy]propyl] adenine fumarate (1:1), the prodrug of tenofovir, the first nucleotide analogue reverse transcriptase inhibitor approved in October 2001 by the Food and Drugs Administration in USA and then, in February 2002, by the European Medicines Evaluation Agency in Europe for the treatment of HIV infection. In a short time it has become one of the most widely prescribed agents in HAART regimens both in naive and experienced patients, and is one of the most frequently used antiretroviral drug in ongoing clinical trials for the treatment but also for the prevention of HIV infection. Why has it gained a so important role in the management of HIV infection? This brief report emphasizes the key aspects of tenofovir, concerning its pharmacokinetic and pharmacodynamic properties, and its therapeutic efficacy and safety.


Tenofovir DF, HIV infection, antiretroviral therapy, resistance, pharmacokinetics, pharmacodynamics, interactions, tolerability.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 7
Issue Number: 4
First Page: 285
Last Page: 295
Page Count: 11
DOI: 10.2174/187152108785908839
Price: $58

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science